medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2016, Number 04

<< Back Next >>

Ginecol Obstet Mex 2016; 84 (04)

Endometrial ablation with thermal balloon, experience in a private hospital

Quesnel-García-Benítez C, Sánchez-Aranda A, López-Rioja MJ

Language: Spanish
References: 12
Page: 201-208
PDF size: 298.16 Kb.


ABSTRACT

Background: Traditionally, the treatment for menorrhagia includes pharmacological therapies (hormones and uterotonics) or surgical (dilatation/curettage and hysterectomy). Recently the FDA approved a non-invasive therapeutic option, known as endometrial ablation. Which it consists in a thermal balloon delivers (ThermaChoice® y Thermablate EAS®) which energy destroys the uterine lining, thus reducing the bleeding and even producing amenorrhea. And could offer other benefits such as reduction of the surgical time, and therefore: anesthesia time, postoperative complications and costs. Highlighting a greater patient satisfaction.
Objetive: Describe the demographic characteristics, outcomes and patient satisfaction, which were treated with endometrial ablation for menorrhagia.
Material and Method: A descriptive, observational and retrospective study. During a period of 11 years (March 2012 to December 2013), in a private hospital, that includes 124 patients with menorrhagia, which were treated with endometrial ablation: 53 (43%) ThermaChoice® y 71 (57%) Thermablate EAS®. We used T Student and Fisher method to study the results.
Results: The 124 patients (100%) achieve all the criteria’s of endometrial ablation according ACOG (American College of Obstetricians and Gynecologists) were candidates for. The mean age of our patients were 38 years old, who didn’t respond to pharmacologic treatment had a definitive contraception. Among these women, 119 (96%) had a reduction in bleeding en the first 12 months, 25 (31%) presented with amenorrhea and 1 (‹1%) required a surgical approach. Overall, 119 patients (96%) were satisfied with their results.
Conclusions: Endometrial ablation is an approved FDA treatment for menorrhagia, which is safe, accessible and effective. With an easy implementation and low rate of complications.


REFERENCES

  1. Scatella AC, Chamy VP, Sovino HS. Ablación endometrial por histeroscopia: resultados, prevención y manejo de complicaciones. Rev Chil Obstet Ginecol 2011;76:439-448.

  2. Casablanca Y. Management of dysfunctional uterine bleeding. Obstet Gynecol Clin North Am 2008; 35:219-234.

  3. Sharp HT. An overview of endometrial ablation. In: UpTo- Date, Basow, DS (Ed), UpToDate, Waltham, MA, 2015.

  4. Fothergill RE. Endometrial ablation in the office setting. Obstet Gynecol Clin North Am 2008;35:317-330.

  5. Endometrial ablation. ACOG Practice Bulletin 81. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;109:1233-48. Reaffirmed 2015.

  6. Singh S, Best C, Dunn S, et al. Abnormal Uterine Bleeding in Pre-Menopausal Women. J Obstet Gynaecol Can 2013;35:S1-S28.

  7. Lethaby A, Hickey M, Garry R, Penninx J. Endometrial resection and ablation techniques for heavy menstrual bleeding (Review). Cochrane Database of Systematic Reviews 2013, Issue 4.

  8. Glasser MH, Heinlein PK, Hung YY. Office endometrial ablation with local anesthesia using the HydroThermAblator system: Comparison of outcomes in patients with submucous myomas with those with normal cavities in 246 cases performed over 5(1/2) years. J Minim Invasive Gynecol 2009;16:700.

  9. Neuwirth RS, Loffer FD, Trenhaile T, et al. The incidence of endometrial cancer after endometrial ablation in a low-risk population. J Am Assoc Gynecol Laparosc 2004;11:492-494.

  10. Practice Committee of American Society for Reproductive Medicine. Indications and options for endometrial ablation. Fertil Steril 2008; 90:S236.

  11. Sanfilippo JS. Options in endometrial ablation. OBG Manag. December; 2005;suppl.

  12. Ethicon (2015). GYNECARE THERMACHOICE® III Uterine Balloon Therapy System. Estados Unidos. Recuperado de www.ethicon360.com/products/gynecare-thermachoiceuterine- balloon-therapy-system. AvISO A LOS LECTORES FEDERADOS La aplicación de la revista GINECOLOGÍA Y OBSTETRICIA DE MÉXICO puede descargarse de manera gratuita en las tiendas Play Store como Ginecol Obstet Mex y App Store como FEMECOG. Esta es otra opción de fácil acceso al acervo histórico y al presente de la revista. Play Store




2020     |     www.medigraphic.com